LexDanaLexDanabeta
Inventor

EUGENE L. STEWART

Inventor
US

Overview

2→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds20%
C07HSugars20%
Y02ATechnologies for adaptation to climate change20%
PatentTitleYear
12,552,824C-mannoside compounds useful for the treatment of urinary tract infections202611,697,665C-mannoside compounds useful for the treatment of urinary tract infections2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to FIMBRION THERAPEUTICS INC (2)· patent assignee history
2023–2026Patents assigned to GLAXOSMITHKLINE IP DEV LTD (2)· patent assignee history
2023–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
FIMBRION THERAPEUTICS INC22023–2026
GLAXOSMITHKLINE IP DEV LTD22023–2026
Locations
LocationPatentsSpan
US22023–2026